Ashland's Sale Exploration Suggests Activist Settlement Was a Prelude
AI-generated image · Bay Street Wire
After reaching an agreement with Ancora Holdings Group, the specialty chemical maker is now engaging with strategic and financial suitors, including major private equity firms.
Opinion: The recent settlement between Ashland Inc. and activist investor Ancora Holdings Group may have been less of a final resolution and more of a strategic bridge toward a full exit. As first reported by the Financial Post, the Wilmington, Delaware-based chemical maker is currently exploring a potential sale after receiving takeover interest.
In my view, the board is now testing Ashland's valuation in a consolidating chemicals market. The decision to engage with suitors follows a settlement with Ancora Holdings Group that included the creation of a capital allocation committee and the addition of two directors to the board. This follows a June conference where Jim Chadwick, head of Ancora Alternatives, suggested a sale could increase Ashland's share price by at least 30%.
Ashland is reportedly working with Lazard Inc. and Citigroup Inc. to manage engagements with financial and strategic bidders. The Financial Post notes that private equity firms including Apollo Global Management Inc., Carlyle Group Inc., and Advent have had contact with the company. Additionally, Standard Industries Inc.—which holds a significant stake via Standard Investments LLC—is also interested.
This openness aligns with industry trends where specialty chemical companies have become attractive plays for energy, power, semiconductors, and artificial intelligence. This was evidenced in July when Solstice Advanced Materials Inc. (a Honeywell International Inc. spinoff) agreed to buy Element Solutions Inc. in a $14.5 billion cash-and-stock deal.
While there is no certainty a transaction will occur, Ashland's shares rose as much as 8% Friday, closing at $76.45 and bringing the market value to $3.5 billion. The stock has climbed 30% this year. Beyond Ancora, Cruiser Capital Advisors supported the board nominations of Peter Thomas and Allen Spizzo as part of the recent settlement. The current trajectory suggests the company is weighing whether a full sale is the most effective way to realize the value demanded by its activist shareholders.